Glucotrack (GCTK) Long-Term Investments (2016 - 2020)
Glucotrack's Long-Term Investments history spans 6 years, with the latest figure at $56911.0 for Q2 2020.
- For the quarter ending Q2 2020, Long-Term Investments rose 2.93% year-over-year to $56911.0, compared with a TTM value of $56911.0 through Jun 2020, up 2.93%, and an annual FY2019 reading of $57092.0, up 8.53% over the prior year.
- Long-Term Investments for Q2 2020 was $56911.0 at Glucotrack, up from $55439.0 in the prior quarter.
- The five-year high for Long-Term Investments was $57092.0 in Q4 2019, with the low at $35673.0 in Q4 2016.
- Average Long-Term Investments over 5 years is $46277.1, with a median of $43768.5 recorded in 2017.
- Year-over-year, Long-Term Investments decreased 4.22% in 2018 and then surged 47.13% in 2019.
- Tracing GCTK's Long-Term Investments over 5 years: stood at $35673.0 in 2016, then rose by 10.9% to $39562.0 in 2017, then skyrocketed by 32.97% to $52605.0 in 2018, then increased by 8.53% to $57092.0 in 2019, then dropped by 0.32% to $56911.0 in 2020.
- Per Business Quant, the three most recent readings for GCTK's Long-Term Investments are $56911.0 (Q2 2020), $55439.0 (Q1 2020), and $57092.0 (Q4 2019).